Dr. Amy Shapiro, MD
Claim this profileIndiana Hemophila @Thrombosis Center
Area of expertise
Hemophilia
Amy Shapiro, MD has run 5 trials for Hemophilia. Some of their research focus areas include:
Hemophilia A
Amy Shapiro, MD has run 4 trials for Hemophilia A. Some of their research focus areas include:
Affiliated Hospitals
Indiana Hemophila @Thrombosis Center
Indiana Hemophilia And Thrombosis Center (IHTC)
Clinical Trials Amy Shapiro, MD is currently running
Natural History Study
for Blood Disorders
In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have not yet demonstrated long-term safety and effectiveness beyond the pivotal trials that led to their approval. In addition, results from well controlled, pivotal studies often cannot be replicated once a therapy has been approved for general use.2,3,4,5 In 2019 alone, the FDA has issued approvals for 24 new therapies for congenital and acquired hematologic conditions.6 In addition, almost 10,000 new studies for hematologic diseases are currently registered on www.clinicaltrials.gov.7 With this increase in potential new therapies possible, it is imperative that clinicians and clinical researchers in the field of non-neoplastic hematology have a uniform, secure, unbiased, and enduring method to collect long-term safety and efficacy data. As emphasized in a recently published review, accurate, uniform and quality national data collection is critical in clinical research, particularly for longitudinal cohort studies covering a lifetime of biologic risk.8
Recruiting
1 award
N/A
1 criteria
Hemlibra
for Mild Hemophilia A
This is a single arm, phase 4, prospective, open-label, United States single-center study to determine the hemostatic characteristics of Hemlibra (emicizumab) as measured by coagulation laboratory parameters in the mild hemophilia A male patient population with endogenous altered FVIII (baseline FVIII activity of \>5% to 30%). The safety and hemostatic efficacy of Hemlibra (emicizumab) in this patient population will be investigated. Secondary outcomes will assess changes in joint health and quality of life in treated patients.
Recruiting
4 awards
Phase 4
More about Amy Shapiro, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Amy Shapiro, MD has experience with
- Emicizumab
- Liver Transplantation
- Clotting Factor Replacement Product
- Various VWF Regimens
- RFVIII
- RVWF
Breakdown of trials Amy Shapiro, MD has run
Hemophilia
Hemophilia A
Hemophilia B
Von Willebrand Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amy Shapiro, MD specialize in?
Amy Shapiro, MD focuses on Hemophilia and Hemophilia A. In particular, much of their work with Hemophilia has involved pdFVIII patients, or patients who are rFVIII.
Is Amy Shapiro, MD currently recruiting for clinical trials?
Yes, Amy Shapiro, MD is currently recruiting for 3 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Amy Shapiro, MD has studied deeply?
Yes, Amy Shapiro, MD has studied treatments such as Emicizumab, Liver Transplantation, Clotting Factor Replacement Product.
What is the best way to schedule an appointment with Amy Shapiro, MD?
Apply for one of the trials that Amy Shapiro, MD is conducting.
What is the office address of Amy Shapiro, MD?
The office of Amy Shapiro, MD is located at: Indiana Hemophila @Thrombosis Center, Indianapolis, Indiana 46260 United States. This is the address for their practice at the Indiana Hemophila @Thrombosis Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.